Cover Image
Market Research Report

End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Global Clinical Trials Review, H1, 2019

Published by GlobalData Product code 326148
Published Content info 504 Pages
Delivery time: 1-2 business days
Price
Back to Top
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Global Clinical Trials Review, H1, 2019
Published: May 31, 2019 Content info: 504 Pages
Description

GlobalData's clinical trial report, "End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Global Clinical Trials Review, H1, 2019" provides an overview of End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) clinical trials scenario. This report provides top line data relating to the clinical trials on End-Stage Kidney Disease (End-Stage Renal Disease or ESRD). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
Product Code: GDHC5712CTIDB

Table of Contents

  • List of Tables
  • List of Figures
  • Report Guidance
  • GlobalData Clinical Trials Report Coverage
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) to Genito Urinary System And Sex Hormones Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) to Genito Urinary System And Sex Hormones Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on End-Stage Kidney Disease (End-Stage Renal Disease or ESRD)
  • May 02, 2019: Dynavax announces first patient enrolled in study of HEPLISAV-B [Hepatitis B Vaccine, Recombinant (Adjuvanted)] in adults with end-stage renal disease
  • Mar 18, 2019: Rockwell Medical Announces I.V. triferic and peritoneal dialysis study abstracts selected as best-in-category at the Annual Dialysis Conference
  • Clinical Trial Profile Snapshots
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
  • Source

List of Tables

  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Clinical Trials by Region, 2019*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Europe, Top Five Countries, 2019*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, North America, Top Countries, 2019*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2019*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2019*
  • Proportion of End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2019*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, G7 Countries, Clinical Trials by Phase, 2019*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019*
  • Proportion of End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2019*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, E7 Countries, Clinical Trials by Phase, 2019*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Clinical Trials by Phase, 2019*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Clinical Trials In Progress by Phase 2019*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Clinical Trials by Trial Status, 2019*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Global, by End Point Status, 2019*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Global, Key Sponsors, 2019*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019*

List of Figures

  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Clinical Trials by Region (%), 2019*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, North America, Top Countries (%), 2019*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2019*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2019*
  • Proportion of End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2019*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, G7 Countries, Clinical Trials by Phase, 2019*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019*
  • Proportion of End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2019*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, E7 Countries, Clinical Trials by Phase, 2019*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Clinical Trials by Phase (%), 2019*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Clinical Trials In Progress by Phase, 2019*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Clinical Trials by Trial Status, 2019*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Global, by End Point Status, 2019*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Global, Key Sponsors, 2019*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019*
  • GlobalData Methodology
Back to Top